リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Fetal Ultrasound and Magnetic Resonance Imaging Abnormalities in Congenital Cytomegalovirus Infection Associated with and without Fetal Growth Restriction」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Fetal Ultrasound and Magnetic Resonance Imaging Abnormalities in Congenital Cytomegalovirus Infection Associated with and without Fetal Growth Restriction

Tanimura, Kenji Uchida, Akiko Uenaka, Mizuki Imafuku, Hitomi Tairaku, Shinya Hashimura, Hiromi Ueno, Yoshiko Kido, Takumi Fujioka, Kazumichi 神戸大学

2023.01

概要

Congenital cytomegalovirus infection (cCMV) can cause fetal growth restriction (FGR) and severe sequelae in affected infants. Clinicians generally suspect cCMV based on multiple ultrasound (US) findings associated with cCMV. However, no studies have assessed the diagnostic accuracy of fetal US for cCMV-associated abnormalities in FGR. Eight FGR and 10 non-FGR fetuses prenatally diagnosed with cCMV were examined by undergoing periodic detailed US examinations, as well as postnatal physical and imaging examinations. The diagnostic accuracy of prenatal US for cCMV-associated abnormalities was compared between FGR and non-FGR fetuses with cCMV. The diagnostic sensitivity rates of fetal US for cCMV-related abnormalities in FGR vs. non-FGR fetuses were as follows: ventriculomegaly, 66.7% vs. 88.9%; intracranial calcification, 20.0% vs. 20.0%; cysts and pseudocysts in the brain, 0% vs. 0%; ascites, 100.0% vs. 100.0%; hepatomegaly, 40.0% vs. 100.0%; splenomegaly, 0% vs. 0%. The diagnostic sensitivity of fetal US for hepatomegaly and ventriculomegaly in FGR fetuses with cCMV was lower than that in non-FGR fetuses with cCMV. The prevalence of severe long-term sequelae (e.g., bilateral hearing impairment, epilepsy, cerebral palsy, and severe developmental delay) in the CMV-infected fetuses with FGR was higher, albeit non-significantly. Clinicians should keep in mind the possibility of overlooking the symptoms of cCMV in assessing fetuses with FGR.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Revello, M.G.; Gerna, G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 2002, 15, 680–715. [CrossRef] [PubMed]

2. Stagno, S.; Whitley, R.J. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N. Engl. J. Med. 1985, 313, 1270–1274. [CrossRef] [PubMed]

3. Kimberlin, D.W.; Jester, P.M.; Sanchez, P.J.; Ahmed, A.; Arav-Boger, R.; Michaels, M.G.; Ashouri, N.; Englund, J.A.; Estrada, B.; Jacobs, R.F.; et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N. Engl. J. Med. 2015, 372, 933–943. [CrossRef] [PubMed]

4. Morioka, I.; Kakei, Y.; Omori, T.; Nozu, K.; Fujioka, K.; Takahashi, N.; Yoshikawa, T.; Moriuchi, H.; Ito, Y.; Oka, A.; et al. Oral Valganciclovir Therapy in Infants Aged< /=2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan. J. Clin. Med. 2022, 11, 3582.

5. Tanimura, K.; Tairaku, S.; Ebina, Y.; Morioka, I.; Nagamata, S.; Deguchi, K.; Morizane, M.; Deguchi, M.; Minematsu, T.; Yamada, H. Prediction of Congenital Cytomegalovirus Infection in High-Risk Pregnant Women. Clin. Infect. Dis. 2017, 64, 159–165. [CrossRef]

6. Imafuku, H.; Yamada, H.; Uchida, A.; Deguchi, M.; Shirakawa, T.; Sasagawa, Y.; Shi, Y.; Fujioka, K.; Morioka, I.; Tanimura, K. Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies. Sci. Rep. 2020, 10, 19706. [CrossRef]

7. Enders, G.; Bader, U.; Lindemann, L.; Schalasta, G.; Daiminger, A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat. Diagn. 2001, 21, 362–377. [CrossRef] [PubMed]

8. Society for Maternal-Fetal Medicin; Hughes, B.L.; Gyamfi-Bannerman, C. Diagnosis and antenatal management of congenital cytomegalovirus infection. Am. J. Obstet. Gynecol. 2016, 214, B5–B11.

9. Leruez-Ville, M.; Ren, S.; Magny, J.F.; Jacquemard, F.; Couderc, S.; Garcia, P.; Maillotte, A.M.; Benard, M.; Pinquier, D.; Minodier, P.; et al. Accuracy of prenatal ultrasound screening to identify fetuses infected by cytomegalovirus which will develop severe long-term sequelae. Ultrasound Obstet. Gynecol. 2021, 57, 97–104. [CrossRef] [PubMed]

10. Khan, N.A.; Kazzi, S.N. Yield and costs of screening growth-retarded infants for torch infections. Am. J. Perinatol. 2000, 17, 131–135. [CrossRef]

11. Yamamoto, R.; Ishii, K.; Shimada, M.; Hayashi, S.; Hidaka, N.; Nakayama, M.; Mitsuda, N. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction. J. Obstet. Gynaecol. Res. 2013, 39, 653–657. [CrossRef]

12. Voekt, C.A.; Rinderknecht, T.; Hirsch, H.H.; Blaich, A.; Hosli, I.M. Ultrasound indications for maternal STORCH testing in pregnancy. Swiss Med. Wkly. 2017, 147, w14534. [CrossRef] [PubMed]

13. Fitzpatrick, D.; Holmes, N.E.; Hui, L. A systematic review of maternal TORCH serology as a screen for suspected fetal infection. Prenat. Diagn. 2022, 42, 87–96. [CrossRef]

14. Leruez-Ville, M.; Stirnemann, J.; Sellier, Y.; Guilleminot, T.; Dejean, A.; Magny, J.F.; Couderc, S.; Jacquemard, F.; Ville, Y. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. Am. J. Obstet. Gynecol. 2016, 215, 342.e341–e349. [CrossRef] [PubMed]

15. Leyder, M.; Vorsselmans, A.; Done, E.; Van Berkel, K.; Faron, G.; Foulon, I.; Naessens, A.; Jansen, A.; Foulon, W.; Gucciardo, L. Primary maternal cytomegalovirus infections: Accuracy of fetal ultrasound for predicting sequelae in offspring. Am. J. Obstet. Gynecol. 2016, 215, 638.e631–638.e638. [CrossRef] [PubMed]

16. Lipitz, S.; Yinon, Y.; Malinger, G.; Yagel, S.; Levit, L.; Hoffman, C.; Rantzer, R.; Weisz, B. Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet. Gynecol. 2013, 41, 508–514. [CrossRef] [PubMed]

17. Tanimura, K.; Shi, Y.; Uchida, A.; Uenaka, M.; Imafuku, H.; Ikuta, T.; Fujioka, K.; Morioka, I.; Deguchi, M.; Minematsu, T.; et al. Immunoglobulin fetal therapy and neonatal therapy with antiviral drugs improve neurological outcome of infants with symptomatic congenital cytomegalovirus infection. J. Reprod. Immunol. 2021, 143, 103263. [CrossRef]

18. Gordijn, S.J.; Beune, I.M.; Thilaganathan, B.; Papageorghiou, A.; Baschat, A.A.; Baker, P.N.; Silver, R.M.; Wynia, K.; Ganzevoort, W. Consensus definition of fetal growth restriction: A Delphi procedure. Ultrasound Obstet. Gynecol. 2016, 48, 333–339. [CrossRef]

19. Molina, L.C.G.; Odibo, L.; Zientara, S.; Obican, S.G.; Rodriguez, A.; Stout, M.; Odibo, A.O. Validation of Delphi procedure consensus criteria for defining fetal growth restriction. Ultrasound Obstet. Gynecol. 2020, 56, 61–66. [CrossRef]

20. Chervenak, F.A.; Jeanty, P.; Cantraine, F.; Chitkara, U.; Venus, I.; Berkowitz, R.L.; Hobbins, J.C. The diagnosis of fetal microcephaly. Am. J. Obstet. Gynecol. 1984, 149, 512–517. [CrossRef]

21. Gaglioti, P.; Danelon, D.; Bontempo, S.; Mombro, M.; Cardaropoli, S.; Todros, T. Fetal cerebral ventriculomegaly: Outcome in 176 cases. Ultrasound Obstet. Gynecol. 2005, 25, 372–377. [CrossRef] [PubMed]

22. Murao, F.; Takamori, H.; Hata, K.; Hata, T.; Kitao, M. Fetal liver measurements by ultrasonography. Int. J. Gynaecol. Obstet. 1987, 25, 381–385. [CrossRef]

23. Schmidt, W.; Yarkoni, S.; Jeanty, P.; Grannum, P.; Hobbins, J.C. Sonographic measurements of the fetal spleen: Clinical implications. J. Ultrasound Med. 1985, 4, 667–672. [CrossRef] [PubMed]

24. Hoddick, W.K.; Mahony, B.S.; Callen, P.W.; Filly, R.A. Placental thickness. J. Ultrasound Med. 1985, 4, 479–482. [CrossRef] [PubMed]

25. La Torre, R.; Nigro, G.; Mazzocco, M.; Best, A.M.; Adler, S.P. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin. Infect. Dis. 2006, 43, 994–1000. [CrossRef]

26. Kono, Y.; Mishina, J.; Sato, N.; Watanabe, T.; Honma, Y. Developmental characteristics of very low-birthweight infants at 18 months’ corrected age according to birthweight. Pediatr. Int. 2008, 50, 23–28. [CrossRef]

27. Tanimura, K.; Tairaku, S.; Morioka, I.; Ozaki, K.; Nagamata, S.; Morizane, M.; Deguchi, M.; Ebina, Y.; Minematsu, T.; Yamada, H. Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection. Clin. Infect. Dis. 2017, 65, 1652–1658. [CrossRef]

28. Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study Group. A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J. Reprod. Immunol. 2012, 95, 73–79.

29. Chaoui, R.; Zodan-Marin, T.; Wisser, J. Marked splenomegaly in fetal cytomegalovirus infection: Detection supported by three-dimensional power Doppler ultrasound. Ultrasound Obstet. Gynecol. 2002, 20, 299–302. [CrossRef]

30. Leruez-Ville, M.; Ghout, I.; Bussieres, L.; Stirnemann, J.; Magny, J.F.; Couderc, S.; Salomon, L.J.; Guilleminot, T.; Aegerter, P.; Benoist, G.; et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am. J. Obstet. Gynecol. 2016, 215, 462.e461–462.e410. [CrossRef] [PubMed]

31. Ito, Y.; Kimura, H.; Torii, Y.; Hayakawa, M.; Tanaka, T.; Tajiri, H.; Yoto, Y.; Tanaka-Taya, K.; Kanegane, H.; Nariai, A.; et al. Risk factors for poor outcome in congenital cytomegalovirus infection and neonatal herpes on the basis of a nationwide survey in Japan. Pediatr. Int. 2013, 55, 566–571. [CrossRef] [PubMed]

32. Tabata, T.; Petitt, M.; Zydek, M.; Fang-Hoover, J.; Larocque, N.; Tsuge, M.; Gormley, M.; Kauvar, L.M.; Pereira, L. Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J. Virol. 2015, 89, 5134–5147. [CrossRef]

33. Doneda, C.; Parazzini, C.; Righini, A.; Rustico, M.; Tassis, B.; Fabbri, E.; Arrigoni, F.; Consonni, D.; Triulzi, F. Early cerebral lesions in cytomegalovirus infection: Prenatal MR imaging. Radiology 2010, 255, 613–621. [CrossRef] [PubMed]

34. Glenn, O.A.; Cuneo, A.A.; Barkovich, A.J.; Hashemi, Z.; Bartha, A.I.; Xu, D. Malformations of cortical development: Diagnostic accuracy of fetal MR imaging. Radiology 2012, 263, 843–855. [CrossRef]

35. Cannie, M.M.; Devlieger, R.; Leyder, M.; Claus, F.; Leus, A.; De Catte, L.; Cossey, V.; Foulon, I.; Van der Valk, E.; Foulon, W.; et al. Congenital cytomegalovirus infection: Contribution and best timing of prenatal MR imaging. Eur. Radiol. 2016, 26, 3760–3769. [CrossRef] [PubMed]

36. Lipitz, S.; Elkan Miller, T.; Yinon, Y.; Weissbach, T.; De-Castro, H.; Hoffman, C.; Katorza, E.; Weisz, B. Revisiting short- and longterm outcome after fetal first-trimester primary cytomegalovirus infection in relation to prenatal imaging findings. Ultrasound Obstet. Gynecol. 2020, 56, 572–578. [CrossRef]

37. Cavoretto, P.I.; Fornara, C.; Baldoli, C.; Arossa, A.; Furione, M.; Candiani, M.; Rovere Querini, P.; Barera, G.; Poloniato, A.; Gaeta, G.; et al. Prenatal Management of Congenital Human Cytomegalovirus Infection in Seropositive Pregnant Patients Treated with Azathioprine. Diagnostics 2020, 10, 542. [CrossRef]

38. Maltezou, P.G.; Kourlaba, G.; Kourkouni, E.; Luck, S.; Blazquez-Gamero, D.; Ville, Y.; Lilleri, D.; Dimopoulou, D.; Karalexi, M.; Papaevangelou, V. Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis. J. Clin. Virol. 2020, 129, 104518. [CrossRef]

39. Roberts, A.B.; Mitchell, J.M.; McCowan, L.M.; Barker, S. Ultrasonographic measurement of liver length in the small-for-gestationalage fetus. Am. J. Obstet. Gynecol. 1999, 180, 634–638. [CrossRef]

40. Hawkins-Villarreal, A.; Moreno-Espinosa, A.L.; Martinez-Portilla, R.J.; Castillo, K.; Hahner, N.; Nakaki, A.; Trigo, L.; Picone, O.; Siauve, N.; Figueras, F.; et al. Fetal Liver Volume Assessment Using Magnetic Resonance Imaging in Fetuses with Cytomegalovirus Infection (dagger). Front. Med. 2022, 9, 889976. [CrossRef]

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る